GANNON STEVEN 4
4 · Xenon Pharmaceuticals Inc. · Filed Mar 8, 2024
Insider Transaction Report
Form 4
GANNON STEVEN
Director
Transactions
- Sale
Common Shares
2024-03-07$46.45/sh−1,000$46,450→ 14,000 total - Sale
Common Shares
2024-03-07$46.30/sh−5,000$231,513→ 4,000 total - Sale
Common Shares
2024-03-07$46.25/sh−5,000$231,250→ 9,000 total - Sale
Common Shares
2024-03-07$46.20/sh−2,000$92,402→ 2,000 total
Footnotes (2)
- [F1]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.3025 to $46.3675, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F2]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.20 to $46.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.